NCT04773717View on ClinicalTrials.gov

The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
SepsisSeptic Shock
Interventions
DRUG

Ascorbic acid

200mg/kg/24h in four equal parts

DRUG

Placebo

The same regimen as ascorbic acid.

Trial Locations (1)

Unknown

Lithuanian University of Health Sciences Hospital Kaunas Clinics, Kaunas

All Listed Sponsors
lead

Lithuanian University of Health Sciences

OTHER

NCT04773717 - The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis | Biotech Hunter | Biotech Hunter